These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12181057)

  • 1. The effect of plasma caeruloplasmin levels on the sensitivity for activated protein C.
    de Visser MC; Souverijn JH; Rosendaal FR; Bertina RM
    Br J Haematol; 2002 Sep; 118(3):843-6. PubMed ID: 12181057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels.
    Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF
    Am J Clin Pathol; 1999 Jun; 111(6):769-72. PubMed ID: 10361512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives.
    Stegeman BH; Helmerhorst FM; Vos HL; Rosendaal FR; Van Hylckama Vlieg A
    J Thromb Haemost; 2012 Oct; 10(10):2061-7. PubMed ID: 22882730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.
    De Mitrio V; Marino R; Cicinelli E; Galantino P; Di Bari L; Giannoccaro F; De Pergola G; Lapecorella M; Schonauer S; Schiraldi O
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):175-82. PubMed ID: 10759011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.
    Raps M; Helmerhorst F; Fleischer K; Thomassen S; Rosendaal F; Rosing J; Ballieux B; VAN Vliet H
    J Thromb Haemost; 2012 Jun; 10(6):992-7. PubMed ID: 22469296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to activated protein C; influence of oral contraceptives and sex.
    Henkens CM; Bom VJ; Seinen AJ; van der Meer J
    Thromb Haemost; 1995 Mar; 73(3):402-4. PubMed ID: 7667823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxaemia induces resistance to activated protein C in healthy humans.
    de Pont AC; Bakhtiari K; Hutten BA; de Jonge E; Vlasuk GP; Rote WE; Levi M; Büller HR; Meijers JC
    Br J Haematol; 2006 Jul; 134(2):213-9. PubMed ID: 16846480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
    Zarychanski R; Houston DS
    Thromb Haemost; 2004 Jun; 91(6):1115-22. PubMed ID: 15175797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.
    Tans G; van Hylckama Vlieg A; Thomassen MC; Curvers J; Bertina RM; Rosing J; Rosendaal FR
    Br J Haematol; 2003 Aug; 122(3):465-70. PubMed ID: 12877675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual consistency of the activated protein C resistance phenotype.
    Tosetto A; Simioni M; Madeo D; Rodeghiero F
    Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced anticoagulant response to activated protein C in patients with IDDM.
    Krugluger W; Kopp HP; Schernthaner G; Hopmeier P
    Diabetes; 1995 Sep; 44(9):1033-7. PubMed ID: 7657025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to activated protein C decreases throughout pregnancy.
    Benedetto C; Marozio L; Tavella AM; Maulà V; Carmignani D; Curti A
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1028-32. PubMed ID: 12421170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.